Mergers & Acquisitions

Greenhill's M&A practice includes some of the most experienced professionals in the industry. Drawing on that experience, we are active across the full range of M&A advisory roles:

Sell-side Advisory

Leveraging our network of experienced Managing Directors, we have a strong track record in sell side advisory roles. Acting for target companies, special board committees or selling shareholders, we can operate at the heart of any process, assist in negotiations and provide incisive and deeply informed advice about the merits of bids received.

Buy-side Advisory

We have a strong record of successful buy side advisory assignments in relation to public or private target companies and are able to advise interested buyers on attractive targets through our global network of relationships.

Merger Advisory

Greenhill is well qualified to assist clients on merger transactions given the long experience of its partners and professionals, an assurance of total discretion. Greenhill has a number of sizeable mergers in its list of completed transactions both in the US and internationally.

Special Advisory

Various advisory work that we undertake does not fit a conventional ‘transaction’ definition. Examples include our work advising the Australian National Rugby League Commission on the sale of television broadcast rights and work for the global partnership of Arthur Andersen in the immediate aftermath of the cases that followed the collapse of Enron. We believe that Greenhill’s experience, expertise and discretion positions us well for special advisory assignments.

Cross-border Advisory

Greenhill’s network of international offices allow us to offer clients a seamless cross-border advisory service with a truly global perspective.

Recent Transactions

11-Feb-25
$320 million (AUD value)
Australia flag
Target: 

Pacific Smiles Group

Australia flag
Acquiror: 
Genesis Capital

Advised Pacific Smiles Group Limited, one of Australia’s leading and fastest growing dental service organisations, on its response to multiple private equity proposals and ultimate sale to Genesis Capital by way of off-market takeover

04-Feb-25
Pending
$1.1 billion
United States flag
Target: 

PRISM Vision Group

United States flag
Acquiror: 
McKesson Corporation

Advising PRISM Vision Group, a leading medical eye care services company, on its majority stake sale to McKesson Corporation, a diversified healthcare services and distribution leader

15-Jan-25
Pending
$390 million
U.S.A., Japan flags
Target: 

Techpoint

Acquiror: 
ASMedia

Advising Techpoint (TSE: 6697), a leading fabless semiconductor company developing high-definition video connectivity technology targeting automotive and security systems, on its $390M sale to ASMedia (TWSE: 5269), a fabless semiconductor company specializing in highspeed transmission interface IC design

14-Jan-25
Pending
$166.5 million (AUD value)
Australia flag
Target: 

Bullabulling Gold Project

Australia flag
Acquiror: 
Minerals 260

Advising Minerals 260 on its purchase of the Bullabulling Gold Project from Norton Gold Fields (a wholly-owned subsidiary of one of the world’s largest gold producers, Zijin Mining Group)

10-Jan-25
Undisclosed
Canada flag
Target: 

Ranger Design

United States flag
Acquiror: 
Clarience Technologies

Advised Ranger Design on its sale to Clarience Technologies, a portfolio company of Genstar Capital 

08-Jan-25
$160 million
United States flag
Target: 

EMG Medallion Delaware Crude

United States flag
Acquiror: 
Plains All American (NASDAQ: PAA)

Advising The Energy & Minerals Group on its Sale of Delaware Basin Crude Assets to Plains All American, a publicly traded master limited partnership which operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids and natural gas

24-Dec-24
Undisclosed
Israel flag
Target: 

Ex-US rights to branded narcolepsy treatments, Provigil® (modafinil) and Nuvigil® (armodafinil)

Germany flag
Acquiror: 
Neuraxpharm Group

Advised Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company, on the acquisition of the ex-US rights to Provigil® (modafinil) and Nuvigil® (armodafinil) from Teva Pharmaceuticals Industries Ltd. (“Teva”)

17-Dec-24
$962 million
Chile Flag
Target: 

Renewable assets in Chile involving hybrid solar power generation and storage

United Kingdom flag
Acquiror: 
Contour Global

Advised ContourGlobal (KKR) in the acquisition of 3 independent solar (Quillagua I & II, and Victor Jara) and BESS projects from Grenergy

12-Dec-24
$460 million
United States flag
Target: 

Brigit

United States flag
Acquiror: 
Upbound Group

Advised Upbound Group, a technology and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, on its acquisition of Brigit, a leading financial health technology company

04-Dec-24
$542 million (CAD value)
Canada flag
Target: 

Heartland Generation

Canada flag
Acquiror: 
TransAlta Corporation

Strategic advisor to Heartland Generation, one of Alberta's largest power generators and an Energy Capital Partners affiliate, on its sale to TransAlta Corporation

Pages

show all